… Monitoring and Treatment Patients with small abdominal aortic aneurysms measuring 3.0 to
3.9 cm in … Both guidelines state that no specific medical therapy has been proven to slow the …

… In a large Cochrane database research of more than 1500 patients that also evaluated the
role of medical treatment, quality of evidence from the collected trials was unclear and did not …

… not all small AAAs (<5.5 cm in diameter) should be disqualified from intervention. Abdominal
aortic aneurysm … aneurysms at a lower aneurysm diameter threshold and in patients with a …

… , medical management to help reduce the risk of aneurysm growth and rupture becomes
paramount. The two main modifiable risk factors for this are smoking and hypertension. While …

… Medical management includes the control of risk factors that may prevent growth, stabilize …
abdominal aortic aneurysm (AAA) is a pathologic dilation of a segment of the abdominal aorta …

… Thus, medical treatments that can slow AAA growth and reduce the risk of small aneurysm
… research performed to test and develop medical therapy to limit AAA growth and rupture. …

… improved abdominal aortic aneurysm (AAA) management over … endovascular treatment has
established its role in daily clinical … Main concerns for optimal preoperative medical treatment …

… of telmisartan on abdominal aortic aneurysm growth rates was … for abdominal aortic aneurysm
repair or aneurysm rupture. … medical therapies to slow abdominal aortic aneurysm growth. …

… Current management of small abdominal aortic aneurysms (AAAs) primarily involves serial
imaging surveillance of maximum transverse diameter (MTD) to estimate rupture risk. Other …

… Patient risk factors are noted in the database but no information on the adequacy of medical
treatment is available. This could be especially significant because racial disparities exist in …